Article

Pharmacogenomic Profiling of Selected Genes Influencing Anti-Diabetic Drug Response in the Pakistani Pashtun Population: Shifting from Trial-and-Error to Precision Medicine

2026-05-19

Abstract excerpt

<title>Abstract</title> <p> Pharmacogenomic (PGx) studies are essential for transitioning from "trial-and-error" prescribing to precision medicine, however there is no substantial studies on pharmacogenomics in Pakistani Pashtun population. This lack of studies in the Pakistani Pashtun cohort hinders the optimization of safety and efficacy of anti-diabetic drugs in Pakistan. This study aimed to identify actionab...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: dcb5e76e-e44f-56ff-8dc8-d00ce3837c72
DOI: 10.21203/rs.3.rs-9412791/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomic Profiling of Selected Genes Influencing Anti-Diabetic Drug Response in the Pakistani Pashtun Population: Shifting from Trial-and-Error to Precision MedicineDOI 10.21203/rs.3.rs-9412791/v1Read

Decoding type 2 diabetes mellitus genetic risk variants in Pakistani Pashtun ethnic population using the nascent whole exome sequencing and MassARRAY genotyping: A case-control association study.Semantic proximity Read

Mining local exome and HLA data to characterize actionable pharmacogenetic variants in Saudi ArabiaSemantic proximity Read

Pharmacogenetic studies update in type 2 diabetes mellitusSemantic proximity Read

Pharmacogenetics of type 2 diabetes mellitus, the route toward tailored medicineSemantic proximity Read

Pharmacogenetics of Oral Antidiabetic DrugsSemantic proximity Read

Current Progress in Pharmacogenetics of Second-Line Antidiabetic Medications: Towards Precision Medicine for Type 2 DiabetesSemantic proximity Read

The global spectrum of protein-coding pharmacogenomic diversity.Semantic proximity Read

Pharmacogenomic landscape of Indian population using whole genomes.Semantic proximity Read

Rare genetic variants in cellular transporters, metabolic enzymes, and nuclear receptors can be important determinants of interindividual differences in drug response.Semantic proximity Read

Validation of Genome-Wide Association Studies (GWAS)-Identified Type 2 Diabetes Mellitus Risk Variants in Pakistani Pashtun Population.Semantic proximity Read

Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations.Semantic proximity Read

Personalized medicine in diabetes: the role of ‘omics’ and biomarkersSemantic proximity Read